Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 1)
Breast Neoplasms (Phase 2)
Breast Neoplasms, Male (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 1)
Gallbladder Neoplasms (Phase 1)
Intestinal Neoplasms (Phase 1)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 1)
Neoplasm Metastasis (Phase 1/Phase 2)
Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Salivary Gland Neoplasms (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Stomach Neoplasms (Phase 1)
Testicular Neoplasms (Phase 1)
Thyroid Neoplasms (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue